{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:08:04Z","timestamp":1790240884388,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021772","name":"Deanship of Scientific Research, University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20200606"],"award-info":[{"award-number":["20200606"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e31266","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T12:38:46Z","timestamp":1715690326000},"page":"e31266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a rapid HPLC-fluorescence method for monitoring warfarin metabolites formation: In vitro studies for evaluating the effect of piperine on warfarin metabolism and plasma coagulation"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0211-1866","authenticated-orcid":false,"given":"Aref L.","family":"Zayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hadieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jomana","family":"Al Hroot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Hameedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana'a A.","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.heliyon.2024.e31266_bib1","first-page":"600","article-title":"Consensus guidelines for warfarin therapy: recommendations from the australasian society of thrombosis and haemostasis","volume":"172","author":"Gallus","year":"2000"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e31266_bib2","first-page":"1239","article-title":"Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans","volume":"22","author":"Miller","year":"2009"},{"key":"10.1016\/j.heliyon.2024.e31266_bib3","first-page":"205","article-title":"Warfarin metabolism and drug-drug interactions","author":"O'Reilly","year":"1987","journal-title":"J.T.n.d.o.w.p"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e31266_bib4","first-page":"667","article-title":"Clinical drugs undergoing polymorphic metabolism by human cytochrome P450 2C9 and the implication in drug development","volume":"18","author":"He","year":"2011"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e31266_bib5","first-page":"4051","article-title":"Drug\u2013drug interactions with warfarin: a systematic review and meta\u2010analysis","volume":"87","author":"Wang","year":"2021"},{"key":"10.1016\/j.heliyon.2024.e31266_bib6","volume":"2014","author":"Ge","year":"2014","journal-title":"Updates on the clinical evidenced herb-warfarin interactions"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e31266_bib7","first-page":"1006","article-title":"A population survey on the use of 24 common medicinal herbs in Australia","volume":"17","author":"Zhang","year":"2008"},{"key":"10.1016\/j.heliyon.2024.e31266_bib8","first-page":"633","article-title":"Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database","volume":"67","author":"Strandell","year":"2011","journal-title":"J.E.j.o.c.p."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31266_bib9","first-page":"49","volume":"45","author":"Shamsi","year":"2017","journal-title":"Curcumin, piperine, and capsaicin: a comparative study of spice-mediated inhibition of human cytochrome P450 isozyme activities"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31266_bib10","first-page":"621","volume":"60","author":"Zhang","year":"2022","journal-title":"Evaluation of the inhibitory effect of quercetin on the pharmacokinetics of tucatinib in rats by a novel UPLC\u2013MS\/MS assay"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e31266_bib11","first-page":"3988","volume":"36","author":"Patil","year":"2022","journal-title":"Molecular dynamics simulation and in vitro evaluation of herb\u2013drug interactions involving dietary polyphenols and CDK inhibitors in breast cancer chemotherapy"},{"key":"10.1016\/j.heliyon.2024.e31266_bib12","first-page":"144","volume":"3","author":"Saleem","year":"2019","journal-title":"Antithrombotic Potential of Ajwa Dates and Piper Nigrum: In Vitro & In Vivo Studies"},{"issue":"20","key":"10.1016\/j.heliyon.2024.e31266_bib13","first-page":"4270","volume":"9","author":"Stojanovi\u0107-Radi\u0107","year":"2019","journal-title":"Piperine-a major principle of black pepper: a review of its bioactivity and studies"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31266_bib14","first-page":"645","volume":"302","author":"Bhardwaj","year":"2002","journal-title":"Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31266_bib15","first-page":"127","article-title":"Study on influence of piperine treatment on the pharmacokinetics of diclofenac in healthy volunteers","volume":"47","author":"Bedada","year":"2017","journal-title":"J.X.,"},{"issue":"15\u201316","key":"10.1016\/j.heliyon.2024.e31266_bib16","first-page":"1056","article-title":"Novel multi-mode ultra performance liquid chromatography\u2013tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma","volume":"879","author":"Jones","year":"2011","journal-title":"J.J.o.C.B."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31266_bib17","first-page":"191","volume":"818","author":"Locatelli","year":"2005","journal-title":"Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31266_bib18","first-page":"343","volume":"70","author":"Zayed","year":"2020","journal-title":"Simultaneous determination of warfarin and 7-hydroxywarfarin in rat plasma by HPLC-FLD"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31266_bib19","first-page":"107","article-title":"Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes","volume":"45","author":"Eagling","year":"1998","journal-title":"J.J.B.j.o.c.p."},{"key":"10.1016\/j.heliyon.2024.e31266_bib20","volume":"2006","year":"2006","journal-title":"London : National Center for the Replacement, Refinement and Reduction of Animals in Research"},{"key":"10.1016\/j.heliyon.2024.e31266_bib21","first-page":"407","volume":"63","author":"Kiridena","year":"2006","journal-title":"Insights into the retention mechanism on a pentafluorophenylpropylsiloxane-bonded silica stationary phase (Discovery HS F5) in RP-LC"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e31266_bib22","first-page":"13","article-title":"Chromatographic classification and comparison of commercially available reversed-phase liquid chromatographic columns using principal component analysis","volume":"994","author":"Euerby","year":"2003","journal-title":"J.J.o.C.A."},{"key":"10.1016\/j.heliyon.2024.e31266_bib23","first-page":"36","volume":"1357","author":"Hayes","year":"2014","journal-title":"Core\u2013shell particles: Preparation, fundamentals and applications in high performance liquid chromatography"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31266_bib24","first-page":"360","article-title":"Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent","volume":"28","author":"Wang","year":"2000"},{"key":"10.1016\/j.heliyon.2024.e31266_bib25","first-page":"587","article-title":"Pharmacogenetics of warfarin elimination and its clinical implications","volume":"40","author":"Takahashi","year":"2001","journal-title":"J.C.p."},{"key":"10.1016\/j.heliyon.2024.e31266_bib26","first-page":"947","article-title":"Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes","volume":"54","author":"Hemeryck","year":"1999","journal-title":"J.E.j.o.c.p."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31266_bib27","first-page":"305","volume":"52","author":"Zuo","year":"2010","journal-title":"Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography\u2013tandem mass spectrometry"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31266_bib28","first-page":"54","volume":"5","author":"Rettie","year":"1992","journal-title":"Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e31266_bib29","first-page":"400","volume":"48","author":"Guo","year":"2018","journal-title":"The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e31266_bib30","first-page":"1195","article-title":"Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R-and S-warfarin enantiomers","volume":"54","author":"Yamazaki","year":"1997","journal-title":"J.B.p."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e31266_bib31","first-page":"541","volume":"21","author":"Takigawa","year":"1998","journal-title":"Inhibition of S-warfarin metabolism by nonsteroidal antiinflammatory drugs in human liver microsomes in vitro"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31266_bib32","first-page":"261","volume":"25","author":"Baldwin","year":"1995","journal-title":"Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e31266_bib33","first-page":"2153","volume":"25","author":"Pohl","year":"1976","journal-title":"Warfarin\u2014stereochemical aspects of its metabolism by rat liver microsomes"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31266_bib34","first-page":"62","volume":"35","author":"Ishizuka","year":"2007","journal-title":"Elevated warfarin metabolism in warfarin-resistant roof rats (Rattus rattus) in Tokyo"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e31266_bib35","first-page":"833","volume":"31","author":"Kobayashi","year":"2003","journal-title":"Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat"},{"key":"10.1016\/j.heliyon.2024.e31266_bib36","series-title":"Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats","first-page":"169","author":"Zayed","year":"2020"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024072979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024072979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:44:44Z","timestamp":1790239484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024072979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024072979"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31266","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a rapid HPLC-fluorescence method for monitoring warfarin metabolites formation: In vitro studies for evaluating the effect of piperine on warfarin metabolism and plasma coagulation","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e31266"}}